264 related articles for article (PubMed ID: 17275129)
41. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
Feng Z; Fan X; Jiao Y; Ban K
Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
[TBL] [Abstract][Full Text] [Related]
42. Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.
Yasui H; Hideshima T; Ikeda H; Ocio EM; Kiziltepe T; Vallet S; Okawa Y; Neri P; Sukhdeo K; Podar K; Chauhan D; Richardson PG; Raje N; Carrasco DR; Anderson KC
Leukemia; 2007 Mar; 21(3):535-40. PubMed ID: 17268521
[TBL] [Abstract][Full Text] [Related]
43. Synergistic effects of β-catenin inhibitors and sorafenib in hepatoma cells.
Muche S; Kirschnick M; Schwarz M; Braeuning A
Anticancer Res; 2014 Sep; 34(9):4677-83. PubMed ID: 25202044
[TBL] [Abstract][Full Text] [Related]
44. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on the proliferation of hepatocellular carcinoma cells].
Tang BD; Zhou Q; Lin QH; Liu SC
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1511-3. PubMed ID: 17959527
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
[TBL] [Abstract][Full Text] [Related]
47. Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.
Egashira I; Takahashi-Yanaga F; Nishida R; Arioka M; Igawa K; Tomooka K; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Kitazono T; Sasaguri T
Cancer Sci; 2017 Jan; 108(1):108-115. PubMed ID: 27761963
[TBL] [Abstract][Full Text] [Related]
48. L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.
Tardito S; Chiu M; Uggeri J; Zerbini A; Da Ros F; Dall'Asta V; Missale G; Bussolati O
Curr Cancer Drug Targets; 2011 Oct; 11(8):929-43. PubMed ID: 21834755
[TBL] [Abstract][Full Text] [Related]
49. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.
Cha MY; Kim CM; Park YM; Ryu WS
Hepatology; 2004 Jun; 39(6):1683-93. PubMed ID: 15185310
[TBL] [Abstract][Full Text] [Related]
51. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
Liu Y; Liu A; Li H; Li C; Lin J
Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
[TBL] [Abstract][Full Text] [Related]
52. Celecoxib-induced increase in cytosolic Ca(2+) levels and apoptosis in HA59T human hepatoma cells.
Cheng HH; Chou CT; Lu YC; Lu T; Chi CC; Tseng LL; Liu SI; Cheng JS; Kuo CC; Liang WZ; Jan CR
Hum Exp Toxicol; 2014 Nov; 33(11):1089-98. PubMed ID: 24972620
[TBL] [Abstract][Full Text] [Related]
53. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of GSK3beta enhances both adhesive and signalling activities of beta-catenin in mouse embryonic stem cells.
Sineva GS; Pospelov VA
Biol Cell; 2010 Aug; 102(10):549-60. PubMed ID: 20626347
[TBL] [Abstract][Full Text] [Related]
55. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
56. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
Kusunoki N; Yamazaki R; Kawai S
Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
[TBL] [Abstract][Full Text] [Related]
57. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
58. Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.
Jin XT; Song L; Zhao JY; Li ZY; Zhao MR; Liu WP
Toxicol Lett; 2014 Feb; 225(1):158-66. PubMed ID: 24355586
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.
Pai R; Dunlap D; Qing J; Mohtashemi I; Hotzel K; French DM
Cancer Res; 2008 Jul; 68(13):5086-95. PubMed ID: 18593907
[TBL] [Abstract][Full Text] [Related]
60. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]